Anti-GT1a Monoclonal Antibody1vial

4-[4-[4,6-Bis[4-(4-carboxyphenyl)phenyl]-1,3,5-triazin-2-yl]phenyl]benzoic acid, 97%, 5g

4-Bromo-1,2,3,6,7,8-hexahydropyrene, 96% GC, 5g

2-((tert-Butoxycarbonyl)amino)-4-methylpentanoic acid, 97%, 10g

Ethyl 5-chloro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 96%, 1g

3-Thiocyanotopropyltriethoxysilane, 95%, 25g

TETRAMETHYLAMMONIUM NITRATE, 95%, 25g

4-Undecanone>95.0%(GC)10mL

2-(2-Nitrovinyl)thiophene>98.0%(GC)25g

5-Bromo-3,4-dihydro-2H-benzo[b][1,4]oxazine, 95.0%, 250mg

1,4-Diamino-2,3-dichloroanthraquinone>93.0%(HPLC)5g

methyl 2-chloro-6-morpholin-4-ylisonicotinate, 10g

tert-Butyl (2-hydroxyphenyl)carbamate, 95.0%, 1g